Literature DB >> 35550177

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.

Pieter Jelle Visser1,2,3, Lianne M Reus4, Johan Gobom5,6, Iris Jansen7, Ellen Dicks4, Sven J van der Lee4,8, Magda Tsolaki9, Frans R J Verhey10, Julius Popp11,12, Pablo Martinez-Lage13, Rik Vandenberghe14,15, Alberto Lleó16, José Luís Molinuevo17,18, Sebastiaan Engelborghs19,20, Yvonne Freund-Levi21,22, Lutz Froelich23, Kristel Sleegers24,25, Valerija Dobricic26, Simon Lovestone27, Johannes Streffer19,28, Stephanie J B Vos10, Isabelle Bos10, August B Smit29, Kaj Blennow5,6, Philip Scheltens4, Charlotte E Teunissen30, Lars Bertram26,31, Henrik Zetterberg5,6,32,33, Betty M Tijms4.   

Abstract

Entities:  

Year:  2022        PMID： 35550177      PMCID： PMC9102351          DOI： 10.1186/s13024-022-00540-0

Source DB:  PubMed          Journal:  Mol Neurodegener        ISSN： 1750-1326            Impact factor:   18.879


× No keyword cloud information.
Correction: Molecular Neurodegeneration 17, 1-16 (2022) https://doi.org/10.1186/s13024-022-00521-3 The original article [1] contained an error in co-author, Lars Bertram’s affiliation which has since been corrected.
  1 in total

1.  Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.

Authors:  Pieter Jelle Visser; Lianne M Reus; Johan Gobom; Iris Jansen; Ellen Dicks; Sven J van der Lee; Magda Tsolaki; Frans R J Verhey; Julius Popp; Pablo Martinez-Lage; Rik Vandenberghe; Alberto Lleó; José Luís Molinuevo; Sebastiaan Engelborghs; Yvonne Freund-Levi; Lutz Froelich; Kristel Sleegers; Valerija Dobricic; Simon Lovestone; Johannes Streffer; Stephanie J B Vos; Isabelle Bos; August B Smit; Kaj Blennow; Philip Scheltens; Charlotte E Teunissen; Lars Bertram; Henrik Zetterberg; Betty M Tijms
Journal:  Mol Neurodegener       Date:  2022-03-28       Impact factor: 14.195
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.